Logo image of GHSI

GUARDION HEALTH SCIENCES INC (GHSI) Stock Fundamental Analysis

NASDAQ:GHSI - Nasdaq - US40145Q5009 - Common Stock - Currency: USD

3.25  -0.01 (-0.31%)

After market: 3.23 -0.02 (-0.62%)

Fundamental Rating

5

GHSI gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 35 industry peers in the Personal Care Products industry. No worries on liquidiy or solvency for GHSI as it has an excellent financial health rating, but there are worries on the profitability. GHSI is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

GHSI had positive earnings in the past year.
In the past year GHSI has reported a negative cash flow from operations.
GHSI had negative earnings in 4 of the past 5 years.
GHSI had a negative operating cash flow in each of the past 5 years.
GHSI Yearly Net Income VS EBIT VS OCF VS FCFGHSI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M -15M -20M

1.2 Ratios

The Return On Assets of GHSI (41.65%) is better than 100.00% of its industry peers.
With an excellent Return On Equity value of 46.34%, GHSI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
ROA 41.65%
ROE 46.34%
ROIC N/A
ROA(3y)-59.1%
ROA(5y)-69.74%
ROE(3y)-76.49%
ROE(5y)-84.1%
ROIC(3y)N/A
ROIC(5y)N/A
GHSI Yearly ROA, ROE, ROICGHSI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1K -1K -2K -3K

1.3 Margins

With an excellent Profit Margin value of 99.10%, GHSI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
GHSI has a Gross Margin of 44.84%. This is comparable to the rest of the industry: GHSI outperforms 41.67% of its industry peers.
In the last couple of years the Gross Margin of GHSI has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 99.1%
GM 44.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.13%
GM growth 5Y-5.18%
GHSI Yearly Profit, Operating, Gross MarginsGHSI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2K -4K -6K -8K

More info and screens

7

2. Health

2.1 Basic Checks

GHSI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, GHSI has more shares outstanding
The number of shares outstanding for GHSI has been increased compared to 5 years ago.
There is no outstanding debt for GHSI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
GHSI Yearly Shares OutstandingGHSI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200K 400K 600K 800K 1M
GHSI Yearly Total Debt VS Total AssetsGHSI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of -5.72, we must say that GHSI is in the distress zone and has some risk of bankruptcy.
GHSI has a Altman-Z score of -5.72. This is amonst the worse of the industry: GHSI underperforms 94.44% of its industry peers.
GHSI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.72
ROIC/WACCN/A
WACC8.73%
GHSI Yearly LT Debt VS Equity VS FCFGHSI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

2.3 Liquidity

GHSI has a Current Ratio of 16.67. This indicates that GHSI is financially healthy and has no problem in meeting its short term obligations.
GHSI's Current ratio of 16.67 is amongst the best of the industry. GHSI outperforms 100.00% of its industry peers.
GHSI has a Quick Ratio of 16.59. This indicates that GHSI is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 16.59, GHSI belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 16.67
Quick Ratio 16.59
GHSI Yearly Current Assets VS Current LiabilitesGHSI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

5

3. Growth

3.1 Past

GHSI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 154.16%, which is quite impressive.
Looking at the last year, GHSI shows a very negative growth in Revenue. The Revenue has decreased by -43.45% in the last year.
GHSI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 67.11% yearly.
EPS 1Y (TTM)154.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%963.44%
Revenue 1Y (TTM)-43.45%
Revenue growth 3Y86.44%
Revenue growth 5Y67.11%
Sales Q2Q%-97.39%

3.2 Future

Based on estimates for the next years, GHSI will show a very negative growth in Earnings Per Share. The EPS will decrease by -110.23% on average per year.
GHSI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.78% yearly.
EPS Next Y-669.3%
EPS Next 2Y-110.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.56%
Revenue Next 2Y9.78%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
GHSI Yearly Revenue VS EstimatesGHSI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
GHSI Yearly EPS VS EstimatesGHSI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 0 -0.5 -1 -1.5 -2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 7.56, the valuation of GHSI can be described as very cheap.
Based on the Price/Earnings ratio, GHSI is valued cheaply inside the industry as 91.67% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.50. GHSI is valued rather cheaply when compared to this.
The Forward Price/Earnings Ratio is negative for GHSI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 7.56
Fwd PE N/A
GHSI Price Earnings VS Forward Price EarningsGHSI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GHSI Per share dataGHSI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8 10

4.3 Compensation for Growth

A cheap valuation may be justified as GHSI's earnings are expected to decrease with -110.23% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-110.23%
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 153.85%, GHSI is a good candidate for dividend investing.
The stock price of GHSI dropped by -67.14% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
GHSI's Dividend Yield is rather good when compared to the industry average which is at 5.72. GHSI pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, GHSI pays a better dividend.
Industry RankSector Rank
Dividend Yield 153.85%

5.2 History

GHSI does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
GHSI Yearly Dividends per shareGHSI Yearly Dividends per shareYearly Dividends per share 2024 1 2 3 4

5.3 Sustainability

DPN/A
EPS Next 2Y-110.23%
EPS Next 3YN/A
GHSI Yearly Income VS Free CF VS DividendGHSI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M -15M -20M

More info and screens

GUARDION HEALTH SCIENCES INC

NASDAQ:GHSI (10/11/2024, 8:01:54 PM)

After market: 3.23 -0.02 (-0.62%)

3.25

-0.01 (-0.31%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-12 2024-08-12/amc
Earnings (Next)11-14 2024-11-14/amc
Inst Owners7%
Inst Owner ChangeN/A
Ins Owners206.25%
Ins Owner Change0%
Market Cap4.39M
Analysts82.86
Price Target40.8 (1155.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 153.85%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-51.78%
Min Revenue beat(2)-97.77%
Max Revenue beat(2)-5.79%
Revenue beat(4)1
Avg Revenue beat(4)-25.02%
Min Revenue beat(4)-97.77%
Max Revenue beat(4)6.34%
Revenue beat(8)2
Avg Revenue beat(8)-14.67%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 7.56
Fwd PE N/A
P/S 0.68
P/FCF N/A
P/OCF N/A
P/B 0.32
P/tB 0.32
EV/EBITDA N/A
EPS(TTM)0.43
EY13.23%
EPS(NY)-1.04
Fwd EYN/A
FCF(TTM)-2.9
FCFYN/A
OCF(TTM)-2.9
OCFYN/A
SpS4.76
BVpS10.19
TBVpS10.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 41.65%
ROE 46.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 99.1%
GM 44.84%
FCFM N/A
ROA(3y)-59.1%
ROA(5y)-69.74%
ROE(3y)-76.49%
ROE(5y)-84.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.13%
GM growth 5Y-5.18%
F-Score6
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 16.67
Quick Ratio 16.59
Altman-Z -5.72
F-Score6
WACC8.73%
ROIC/WACCN/A
Cap/Depr(3y)9.76%
Cap/Depr(5y)24.37%
Cap/Sales(3y)0.36%
Cap/Sales(5y)4.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)154.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%963.44%
EPS Next Y-669.3%
EPS Next 2Y-110.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-43.45%
Revenue growth 3Y86.44%
Revenue growth 5Y67.11%
Sales Q2Q%-97.39%
Revenue Next Year9.56%
Revenue Next 2Y9.78%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.97%
OCF growth 3YN/A
OCF growth 5YN/A